Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q2 2023 Earnings Call Transcript August 10, 2023
Accelerate Diagnostics, Inc. misses on earnings expectations. Reported EPS is $-2.36 EPS, expectations were $-1.5.
Operator: Good day, and welcome to the Accelerate Diagnostics, Inc. 2023 Q2 Results Conference Call. [Operator Instructions]. I would now like to turn the conference over to Laura Pierson, of Accelerate Diagnostics. Please go ahead.
Laura Pierson: Before we begin, it is important to share...
